Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gema Ariceta

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
Pediatric Nephrology (Berlin, Germany)|January 30, 2019
Optimal duration of treatment with eculizumab in atypical hemolytic uremic syndrome (aHUS)-a question to be addressed in a scientific wayGema Ariceta
European Journal of Pediatrics|November 11, 2010
Clinical practice: proteinuriaGema Ariceta
Expert Review of Clinical Pharmacology|May 2, 2023
Pharmacological and clinical profile of ravulizumab 100 mg/mL formulation for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndromeGema Ariceta
Pediatric Nephrology (Berlin, Germany)|July 2, 2024
A better future for children with STEC-hemolytic uremic syndrome: news from ArgentinaGema Ariceta, Gianluigi Ardissino
Pediatric Nephrology (Berlin, Germany)|June 5, 2009
Growth failure associated with sirolimus: case reportGloria A Rangel, Gema Ariceta
Seminars in Nephrology|February 6, 2007
Inherited renal tubulopathies associated with metabolic alkalosis: effects on blood pressureGema Ariceta, Juan Rodríguez-Soriano
European Journal of Pediatrics|December 16, 2006
Growth in X-linked hypophosphatemic ricketsGema Ariceta, Craig B Langman
Pediatric Nephrology (Berlin, Germany)|February 7, 2024
WT1-related disorders: more than Denys-Drash syndromeMercedes Lopez-Gonzalez, Gema Ariceta
Pediatric Nephrology (Berlin, Germany)|December 21, 2017
Effects of long-term cysteamine treatment in patients with cystinosisGema Ariceta, Vincenzo Giordano, Fernando Santos
Clinical Journal of the American Society of Nephrology : CJASN|July 5, 2024
Primary Distal Renal Tubular Acidosis: Toward an Optimal Correction of Metabolic AcidosisElba Medina, Gema Ariceta, Daniel Batlle
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
Pediatric Nephrology (Berlin, Germany)|January 30, 2019
Optimal duration of treatment with eculizumab in atypical hemolytic uremic syndrome (aHUS)-a question to be addressed in a scientific wayGema Ariceta
European Journal of Pediatrics|November 11, 2010
Clinical practice: proteinuriaGema Ariceta
Expert Review of Clinical Pharmacology|May 2, 2023
Pharmacological and clinical profile of ravulizumab 100 mg/mL formulation for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndromeGema Ariceta
Pediatric Nephrology (Berlin, Germany)|July 2, 2024
A better future for children with STEC-hemolytic uremic syndrome: news from ArgentinaGema Ariceta, Gianluigi Ardissino
Pediatric Nephrology (Berlin, Germany)|June 5, 2009
Growth failure associated with sirolimus: case reportGloria A Rangel, Gema Ariceta
Seminars in Nephrology|February 6, 2007
Inherited renal tubulopathies associated with metabolic alkalosis: effects on blood pressureGema Ariceta, Juan Rodríguez-Soriano
European Journal of Pediatrics|December 16, 2006
Growth in X-linked hypophosphatemic ricketsGema Ariceta, Craig B Langman
Pediatric Nephrology (Berlin, Germany)|February 7, 2024
WT1-related disorders: more than Denys-Drash syndromeMercedes Lopez-Gonzalez, Gema Ariceta
Pediatric Nephrology (Berlin, Germany)|December 21, 2017
Effects of long-term cysteamine treatment in patients with cystinosisGema Ariceta, Vincenzo Giordano, Fernando Santos
Clinical Journal of the American Society of Nephrology : CJASN|July 5, 2024
Primary Distal Renal Tubular Acidosis: Toward an Optimal Correction of Metabolic AcidosisElba Medina, Gema Ariceta, Daniel Batlle
Pageof 20